Charting the "unknown unknowns" of cancer progression

Sci Transl Med. 2017 Jul 26;9(400):eaao0959. doi: 10.1126/scitranslmed.aao0959.

Author

Hani Goodarzi^{1

2

3}

Affiliations

¹ Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA 94158, USA.
² Department of Urology, University of California, San Francisco, San Francisco, CA 94158, USA.
³ Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94158, USA. Email: hani.goodarzi@ucsf.edu.

PMID: 28747512
DOI: 10.1126/scitranslmed.aao0959

Abstract

Integrated computational and experimental strategies reveal previously unknown regulatory programs underlying metastatic disease.

Copyright © 2017 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Publication types

Review

MeSH terms

Algorithms
Animals
Gene Expression Profiling / methods
Gene Expression Regulation, Neoplastic / genetics
Humans
Neoplasm Metastasis / genetics*